UroGen Pharma Ltd. (NASDAQ:URGN) Just Reported, And Analysts Assigned A US$39.93 Price Target [Yahoo! Finance]
UroGen Pharma Ltd (URGN) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]
Urogen Pharma (URGN) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025
UroGen Pharma to Present at the Guggenheim Securities Healthcare Innovation Conference